title: Is there a role for targeted medical therapies in patients with craniopharyngiomas?
authors.affiliation: Neuroendocrine Unit, Massachusetts General Hospital, Zero Emerson Place, Suite 112, Boston, MA 02114, USA.|Harvard Medical School, Boston, MA 02115, USA.
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Tritos
mesh_terms: D003397:Craniopharyngioma / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D058990:Molecular Targeted Therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
keywords: BRAF; adamantinomatous craniopharyngioma; dabrafenib; papillary craniopharyngioma; vemurafenib